Summary

Group Director, Global Medicines Development, Cardiovascular & metabolic Diseases (CVMD), AstraZeneca, R&D Mölndal, Sweden Owner of ExpMed Pharma Consulting, a consultancy firm offering services in drug development and clinical pharmacology. Currently on hold due to employment by AstraZeneca   MD, PhD, Associate Professor of Clinical Pharmacology, Karolinska Institutet Board certified in Clinical Pharmacology and Clinical ChemistryLeading positions in Experimental Medicine/Clinical Pharmacology/Early Clinical Development at AstraZeneca and Ferring PharmaceuticalsExperience from different therapeutic areas including neuroscience, cardiovascular, endocrinology/metabolism, urology, fertility and intensive carePharma experience includes NDA/MAA filing, early clinical development strategies (PoP/PoC strategies), early phase in-licensing, regulatory and KOL interactions   Author of 22 scientific papers in peer-reviewed journals   Key areas of interest: innovative drug development, clinical pharmacology, leadership & people management

Work History

Work History
2005 - Present

Senior Research Physician

AstraZeneca

The role included medical and scientific responsibility for the early clinical development plan for a key neuroscience project in neurodegeneration (AD).

May 2012 - Present

Group Director

AstraZeneca
jhjvkjgköjnbgknbgkjnköjbnkblgblb
Aug 2009 - May 2012

Owner

ExpMed Pharma Consulting

Own consultancy firm providing services in Clinical Pharmacology and Early Drug development to companies and academic institutes.

Aug 2005 - Jul 2009

Executive Director

Ferring Pharmaceuticals

The role entailed global responsibility for Experimental Medicine in Ferring (Clinical Pharmacology, Pharmacokinetics & Modeling, Pharmacogenetics and Biomarkers).  Exp Med is responsible for early clinical development (First-in-Man up to Proof-of-Principle/Proof-of-Concept) including regulatory clinical pharmacology programmes. Exp Med also supports late-phase and life-cycle management activities in the company. Exp Med The department has a staff of 12 people with medical, scientific and operational competencies.

2002 - 2004

Head of Clinical Pharmacology

AstraZeneca

The role entailed management of the Clinical Pharmacology group at the site, a group of 16 people (medics, scientists and pharmacokineticists). In addition, the role involved direct medical and scientific responsibility for early phase studies. 

2000 - 2002

Senior Physician and Head of Drug Research & Information Centre

Huddinge University Hospital

The Drug Research & Information Centre provides evidence-based information on drugs in response to queries from health care professionals.

1998 - 2002

Scientific Secretary of the Advisory Committee on Pharmacotherapy

Huddinge University Hospital

The committee is responsible for evidence-based selection of all therapeutic agents used in the hospital.

Education

Education
2002 - Present

Associate Professor

2004 - Present

AstraZeneca

Leadership from three perspectives: Organisational-Group-Individual, based on the Human Element Concept developed by Will Schultz.

2006 - Present

Center for Creative Leadership

"The Looking Glass Experience", a senior level leadership development program

Oct 2013 - Present

Insigniam
<html />
2003 - 2005

Certificate in Pharmaceutical Medicine

University of Basel Pharma Center

Extensive and in-depth educational program in Pharmaceutical Medicine covering all aspect of drug development

2000

Specialist in Clinical Pharmacology

Karolinska Institute at Huddinge University Hospital
1997

Specialist in Clinical Chemistry

Karolinska Institute at Huddinge University Hospital
1993

PhD

Karolinska Institute
1984

MD

Damascus University
<html />

Certifications

Certifications
1997 - Present

Board Certification in Clinical Chemistry

Swedish Board for Health and Welfare
1993 - Present

Licence to practice medicine in Sweden

Swedish Board for Health and Welfare
2005 - Present

Certificate in Pharmaceutical Medicine

University of Basel, Switzerland
2000

Board Certification in Clinical Pharmacology

Swedish Board for Health and Welfare